IJR News — today's news from every side

IJR News — today's news from every side

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

FDA Extends Capricor Deramiocel BLA Review — Aug 24, 2026Capricor Therapeutics announced that the FDA has extended the PDUFA target action date for its Deramiocel BLA for Duchenne muscular dystrophy from August 22, 2026 to November 22, 2026, following the submission of a BLA amendment with 24-month HOPE-3 open-label data and analyses supporting a refined indication focused on preserving upper limb function. The FDA classified the amendment as a major review and Capricor contends the extended data strengthen the case for addressing a significant unmet medical need in DMD, with HOPE-3 meeting its primary endpoint.

Bernstein Liebhard sues GoDaddy, Capricor and three other firms over alleged misstatements — Sep 3, 2026Bernstein Liebhard LLP announced securities class-action lawsuits on behalf of investors against Capricor, GoDaddy, Hyliion, GPGI, and Megan Holdings for alleged misleading statements and inflated stock prices during their respective class periods, urging eligible shareholders to join by submitting forms.

Capricor investor lawsuit deadline nears amid claims of hidden FDA changes — Aug 31, 2026Multiple firms have filed or announced securities class actions against Capricor Therapeutics over allegations that the company changed its statistical analysis plan for its Duchenne drug Deramiocel without FDA agreement, contributing to a 64% stock drop after July 27 briefing documents were released; lead plaintiff deadlines are set for September 28, 2026. The lawsuits allege false and misleading statements and highlight ongoing regulatory scrutiny as the FDA extended review timelines, with firms urging affected investors to seek appointment as lead plaintiffs.

Video — YouTubeJon on Trump's Meme Assault on Canada & the Alternate Reality He's Constructed | The Daily ShowThe Daily Show · 8.4M views · Sep 9, 2026

Capricorn Energy Unsponsored ADR Short Interest Surges 5,000%Business — Jul 24, 2026July saw dramatic short-interest moves across several micro-cap stocks: Capricorn Energy surged to 204 shares (up 5,000%), Cyanotech jumped to 2,938 shares (up 2,477%), Carnarvon Energy declined to 99 shares (down 99.3%), and CV Sciences fell to 6,360 shares (down 96%), with corresponding near-term coverage dynamics noted for these names.

IJRWhite House Weighs Using Defense Production Act To Expand Oil Refining, Report SaysSimon August · 3 min · 14h

De Blasio Sued for ‘Arbitrary and Capricious’ Vaccine Mandate by NYC RestaurantsReporting — Aug 19, 2021New York City Mayor Bill de Blasio (D) is being sued by a group of restaurant owners and five small businesses to block his COVID-19 vaccine mandate. “This vaccine mandate is arbitrary and capricious due to the fact…

RankingBest Pop Albums of All TimePop albums have defined generations through catchy hooks, emotional depth, and massive cultural moments. From Thriller's record-breaking sales to modern streaming giants, these records shaped the sound of popular music. Vote for your favorites to rank them.728 votes · 26 candidates

Photronics investors urged ahead of September 4 deadline — Aug 23, 2026Multiple investor-rights law firms are signaling securities class actions against firms including Photronics, Capricor Therapeutics, BlackRock TCP Capital, and Insulet, with deadlines in 2026 for lead plaintiff status and ongoing litigation alleges misstatements or fraudulent omissions. Investors are urged to review claims and consider joining the suits before deadlines, as lawsuits allege issues ranging from misleading data on drug trials to failed disclosures and stock drops.

ELEKTROS Shares Jump 23% on EV Charging ExpansionFinance — Jul 20, 2026Several European equity short-selling updates emerged: Eleva Capital became a new disclosed short seller in AAK at 0.53% of shares, while Capricorn Fund Managers no longer remains a public short seller in Elekta; Ilex Capital Partners entered as a new public short-seller in Essity at 0.5%, and Millennium Capital joined Elekta as a new public short-seller at 0.59%. Overall short positions are disclosed and monitored under local regulatory thresholds, highlighting active adjustments in targeted stocks.

Sean ‘Diddy’ Combs Ex-Assistant Alleges He Threatened to Kill Her — May 28, 2025Sean “Diddy” Combs ‘ ex-assistant Capricorn Clark alleged in court that the music mogul threatened to kill her on her first day of work. According to Fox News , in 2004 Clark arrived for her first day of work as Combs’…

Aussie Cop Quits Force, Issues Withering Statement on the Elite's Destruction of Freedom Under COVIDOpinion — Oct 16, 2021There are few democratic governments that have been so capricious and petty with the power afforded to them by COVID-induced fear as Australia, a nation that has locked down China-style over a handful of cases and where…

On X · @phinyanechThai GL Actress Tangkwa Shares Excited Video Moment with Co-Star Nurdesoraya from “4E Our Infinite Moments” EventThai actress Tangkwa posted a short excited video tagging Nurdesoraya from the “4E Our Infinite Moments” event. The clip is trending in the Thai GL fandom as fans celebrate the TKNur ship interaction with enthusiastic comments and shares. Reactions are almost entirely positive with no meaningful opposition.1,167 likes · 6m